These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10758953)

  • 21. Point-of-care assessment of platelet reactivity after clopidogrel to predict myonecrosis in patients undergoing percutaneous coronary intervention.
    Mangiacapra F; Barbato E; Patti G; Gatto L; Vizzi V; Ricottini E; D'Ambrosio A; Wijns W; Di Sciascio G
    JACC Cardiovasc Interv; 2010 Mar; 3(3):318-23. PubMed ID: 20298992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prognostic significance of the elevation of the indices of myocardial damage after percutaneous coronary revascularization interventions].
    Cavallini C; Savonitto S
    Ital Heart J Suppl; 2002 Mar; 3(3):286-96. PubMed ID: 12040844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention.
    Ioannidis JP; Karvouni E; Katritsis DG
    J Am Coll Cardiol; 2003 Oct; 42(8):1406-11. PubMed ID: 14563583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of creatine kinase-MB elevation after percutaneous coronary intervention in patients with chronic renal dysfunction.
    Jeremias A; Albirini A; Ziada KM; Chew DP; Brener SJ; Topol EJ; Ellis SG
    Am Heart J; 2002 Jun; 143(6):1040-5. PubMed ID: 12075261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravascular ultrasound-guided percutaneous transluminal coronary angioplasty with provisional spot stenting for treatment of long coronary lesions.
    Colombo A; De Gregorio J; Moussa I; Kobayashi Y; Karvouni E; Di Mario C; Albiero R; Finci L; Moses J
    J Am Coll Cardiol; 2001 Nov; 38(5):1427-33. PubMed ID: 11691519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Study on the relationship between aspirin resistance and incidence of myonecrosis after non-emergent percutaneous coronary intervention].
    Zhang Y; Liang J; Zhou YJ; Yuan H; Zhang YZ; Dong L
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Aug; 33(8):695-9. PubMed ID: 16188050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. beta-blockers before percutaneous coronary intervention do not attenuate postprocedural creatine kinase isoenzyme rise.
    Ellis SG; Brener SJ; Lincoff AM; Moliterno DJ; Whitlow PL; Schneider JP; Topol EJ
    Circulation; 2001 Nov; 104(22):2685-8. PubMed ID: 11723019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of myocardial enzyme release after coronary interventions.
    Kelly D; Arora R
    Catheter Cardiovasc Interv; 1999 Mar; 46(3):292-302. PubMed ID: 10348125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Value of a new multiparametric score for prediction of microvascular obstruction lesions in ST-segment elevation myocardial infarction revascularized by percutaneous coronary intervention.
    Amabile N; Jacquier A; Gaudart J; Sarran A; Shuaib A; Panuel M; Moulin G; Bartoli JM; Paganelli F
    Arch Cardiovasc Dis; 2010 Oct; 103(10):512-21. PubMed ID: 21130964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Creatine kinase-MB elevation following stent implantation.
    Ioannidis JP; Karvouni E; Katritsis DG
    J Am Coll Cardiol; 2005 Jun; 45(11):1908; author reply 1908-9. PubMed ID: 15936632
    [No Abstract]   [Full Text] [Related]  

  • 31. Troponin I elevation and cardiac events after percutaneous coronary intervention.
    Ricciardi MJ; Davidson CJ; Gubernikoff G; Beohar N; Eckman LJ; Parker MA; Bonow RO
    Am Heart J; 2003 Mar; 145(3):522-8. PubMed ID: 12660677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microvascular obstruction in acute coronary syndromes: onward to a new therapeutic target.
    Schwartz RS
    Catheter Cardiovasc Interv; 2005 Oct; 66(2):170-2. PubMed ID: 16142803
    [No Abstract]   [Full Text] [Related]  

  • 33. [Prevention of periprocedural myocardial damage in patients undergoing percutaneous coronary intervention].
    Patti G; Pasceri V; Nusca A; Di Sciascio G
    Ital Heart J Suppl; 2005 Sep; 6(9):553-60. PubMed ID: 16281714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sustained suppression of ischemic complications of coronary intervention by platelet GP IIb/IIIa blockade with abciximab: one-year outcome in the EPILOG trial. Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockade.
    Lincoff AM; Tcheng JE; Califf RM; Kereiakes DJ; Kelly TA; Timmis GC; Kleiman NS; Booth JE; Balog C; Cabot CF; Anderson KM; Weisman HF; Topol EJ
    Circulation; 1999 Apr; 99(15):1951-8. PubMed ID: 10208997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Catastrophic outcomes of noncardiac surgery soon after coronary stenting.
    Kałuza GL; Joseph J; Lee JR; Raizner ME; Raizner AE
    J Am Coll Cardiol; 2000 Apr; 35(5):1288-94. PubMed ID: 10758971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Admission troponin T level predicts clinical outcomes, TIMI flow, and myocardial tissue perfusion after primary percutaneous intervention for acute ST-segment elevation myocardial infarction.
    Giannitsis E; Müller-Bardorff M; Lehrke S; Wiegand U; Tölg R; Weidtmann B; Hartmann F; Richardt G; Katus HA
    Circulation; 2001 Aug; 104(6):630-5. PubMed ID: 11489766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical and angiographic predictors of creatine kinase enzyme elevation after successful coronary stent implantation: effects on subsequent target vessel revascularization].
    Babalik E; Orta K; Gürmen T; Okçün B; Gülbaran M; Oztürk S
    Anadolu Kardiyol Derg; 2003 Jun; 3(2):107-12. PubMed ID: 12826502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty.
    Al Suwaidi J; Holmes DR; Salam AM; Lennon R; Berger PB
    Am Heart J; 2004 May; 147(5):815-22. PubMed ID: 15131536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of statins prior to percutaneous coronary intervention reduces myonecrosis and improves clinical outcome.
    Chang SM; Yazbek N; Lakkis NM
    Catheter Cardiovasc Interv; 2004 Jun; 62(2):193-7. PubMed ID: 15170709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MGUard versus bAre-metal stents plus manual thRombectomy in ST-elevation myocarDial infarction pAtieNts-(GUARDIAN) trial: study design and rationale.
    Cassese S; Esposito G; Mauro C; Varbella F; Carraturo A; Montinaro A; Cirillo P; Galasso G; Rapacciuolo A; Piscione F
    Catheter Cardiovasc Interv; 2012 Jun; 79(7):1118-26. PubMed ID: 22105879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.